Related Experiment Video
Updated: Apr 6, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.8K
HCV Kinetic Models and Their Implications in Drug Development
1IAME, UMR 1137, INSERM Paris, France ; IAME, UMR 1137, Univ. Paris Diderot, Sorbonne Paris Cité Paris, France.
CPT: Pharmacometrics & Systems Pharmacology
|July 31, 2015
Summary
Mathematical models track hepatitis C virus (HCV) infection dynamics. These models offer insights into the viral life cycle and effectiveness of antiviral treatments, aiding in the development of new anti-HCV agents.
Area of Science:
- Virology
- Mathematical Biology
- Pharmacology
Background:
- Chronic hepatitis C virus (HCV) infection impacts 170 million globally.
- HCV is a leading cause of severe liver disease.
- Understanding viral dynamics is crucial for effective treatment.
Purpose of the Study:
- To review the role of viral kinetic models in anti-HCV drug development.
- To highlight how modeling informs understanding of HCV lifecycle and drug mechanisms.
- To discuss the application of these models across different stages of anti-HCV agent development.
Main Methods:
- Review of existing literature on mathematical modeling of HCV kinetics.
- Analysis of viral kinetic models applied to treatment studies.
- Synthesis of findings on model implications for drug development.
Main Results:
- Viral kinetic models provide critical insights into HCV replication and drug action.
- Models help predict treatment outcomes and optimize therapeutic strategies.
- Model-based approaches are valuable throughout the anti-HCV agent development pipeline.
Conclusions:
- Mathematical modeling is an indispensable tool in advancing hepatitis C therapeutics.
- Kinetic models facilitate a deeper understanding of HCV infection and drug efficacy.
- Continued application of modeling will accelerate the development of novel anti-HCV therapies.
More Related Videos
Related Concept Videos
01:20Pharmacokinetic Models: Overview
2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
01:27Pharmacodynamic Models: Overview
91
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
91
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
72
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
72
01:26Pharmacokinetic Models: Comparison and Selection Criterion
456
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
456
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
143
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
143
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
378
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
378